Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgardo S Santos

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Expert Review of Anticancer Therapy|March 7, 2020
Treatment options after first-line immunotherapy in metastatic NSCLCEdgardo S Santos
Targeted Oncology|June 21, 2025
Dermatologic Adverse Event Mitigation and Management Strategies with Amivantamab + Lazertinib Therapy for Advanced Non-Small Cell Lung Cancer: A VodcastDanny Nguyen, Edgardo S Santos
Oncotargets and Therapy|October 16, 2020
Advanced Squamous Cell Carcinoma of the Lung: Current Treatment Approaches and the Role of AfatinibEdgardo S Santos, Lowell Hart
Clinical Lung Cancer|July 25, 2022
Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the LungEdgardo S Santos, Estelamari Rodriguez
Lung Cancer Management|June 7, 2023
Treatment considerations for patients with advanced squamous cell carcinoma of the lung: a plain language summaryEdgardo S Santos, Estelamari Rodriguez
Expert Review of Anticancer Therapy|March 7, 2007
Rituximab and its role as maintenance therapy in non-Hodgkin lymphomaBridgette Collins-Burow, Edgardo S Santos
Expert Review of Anticancer Therapy|October 14, 2005
Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemiaEdgardo S Santos, Mohamad Masri, Hana Safah
Clinical Lung Cancer|July 7, 2011
Biomarkers, prediction, and prognosis in non-small-cell lung cancer: a platform for personalized treatmentAkshay Sudhindra, Roberto Ochoa, Edgardo S Santos
Expert Review of Anticancer Therapy|October 31, 2006
New horizons in multiple myeloma therapyEdgardo S Santos, Mohamed A Kharfan-Dabaja
Expert Review of Anticancer Therapy|October 16, 2004
Role of farnesyltransferase inhibitors in hematologic malignanciesEdgardo S Santos, Joseph D Rosenblatt, Mark Goodman
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Expert Review of Anticancer Therapy|March 7, 2020
Treatment options after first-line immunotherapy in metastatic NSCLCEdgardo S Santos
Targeted Oncology|June 21, 2025
Dermatologic Adverse Event Mitigation and Management Strategies with Amivantamab + Lazertinib Therapy for Advanced Non-Small Cell Lung Cancer: A VodcastDanny Nguyen, Edgardo S Santos
Oncotargets and Therapy|October 16, 2020
Advanced Squamous Cell Carcinoma of the Lung: Current Treatment Approaches and the Role of AfatinibEdgardo S Santos, Lowell Hart
Clinical Lung Cancer|July 25, 2022
Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the LungEdgardo S Santos, Estelamari Rodriguez
Lung Cancer Management|June 7, 2023
Treatment considerations for patients with advanced squamous cell carcinoma of the lung: a plain language summaryEdgardo S Santos, Estelamari Rodriguez
Expert Review of Anticancer Therapy|March 7, 2007
Rituximab and its role as maintenance therapy in non-Hodgkin lymphomaBridgette Collins-Burow, Edgardo S Santos
Expert Review of Anticancer Therapy|October 14, 2005
Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemiaEdgardo S Santos, Mohamad Masri, Hana Safah
Clinical Lung Cancer|July 7, 2011
Biomarkers, prediction, and prognosis in non-small-cell lung cancer: a platform for personalized treatmentAkshay Sudhindra, Roberto Ochoa, Edgardo S Santos
Expert Review of Anticancer Therapy|October 31, 2006
New horizons in multiple myeloma therapyEdgardo S Santos, Mohamed A Kharfan-Dabaja
Expert Review of Anticancer Therapy|October 16, 2004
Role of farnesyltransferase inhibitors in hematologic malignanciesEdgardo S Santos, Joseph D Rosenblatt, Mark Goodman
Pageof 8